Dr. Deepak Koppaka - Oncology - CARE Hospitals
Video Consultation Appointment Request   Covid Care Package @ Home

Book An Appointment

BookAppointment

Book An Appointment

  • Education
  • Past Positions
  • Skills / Expertise
  • Publications
  • Research Presentations
  • Memberships
  • Awards & Recognition
  • Bio

Education

  • MBBS from G.S.L. Medical College, Rajahmundary in March, 2011
  • MD (Radiation Oncology) from Postgraduate Institute Of Medical Education And Research (PGIMER), Chandigarh in December, 2014
  • DM (Medical Oncology) from Kidwai Cancer Institute, Bangalore in July, 2018

Past Positions

  • CONSULTANT MEDICAL ONCOLOGIST AMERICAN ONCOLOGY INSTITUTE/CITIZENS

Skills / Expertise

  • Treatment and counselling patients receiving systemic therapies for solid and haematological malignancies: Chemotherapy, Hormonal therapies, biological therapies, Targeted Therapy, Immunotherapy
  • Prescribe and administer Chemotherapy, biological therapy, Immunotherapy, Targeted therapy
  • Diagnose and Manage side effects of anti-cancer treatments
  • Perform central line insertion, PICC line insertion, Bone Marrow Aspiration and Biopsy, lumbar puncture and intrathecal drug administration
  • Perform image-guided tru-cut biopsies, FNAC’s, pleural and peritoneal paracentesis
  • Diagnose and Manage medical and oncological emergencies
  • Autologous stem-cell transplant for Hodgkin’s lymphoma, Non-Hodgkin’s lymphoma, Multiple Myeloma
  • Induction and consolidation chemotherapies for ALL/AML
  • Management of malignancies in patients with HIV/AIDS
  • Participate and contribute in a Multidisciplinary clinic

Publications

  • I. Articles
  • 1. Koppaka D, Kapoor R, Bahl A, Bansal A, Mittal BR, et al. (2015) Impact of Integrating Pet-Ct in Radiotherapy Planning of Non-small Cell Carcinoma Lung: Dosimetric and Radiobiological Comparison. J Integr Oncol 4:139. doi:10.4172/2329-6771.1000139.
  • 2. Abraham, Linu, A Rudresha, Smitha Saldanha, Deepak Koppaka, Lakshmaiah Kuntegowdanahalli, Lokanatha Dasappa, and Pretesh Kiran. 2016. 'Gemcitabine-induced supraventricular tachycardia: A rare manifestation', Clinical Cancer Investigation Journal, 5: 200-02.
  • Haleshappa RA, Koppaka D, Thanky AH, Padma M, Amirtham U, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Genito-Urinary Malignancies In Patients With Disorders Of Sexual Development: An Experience From A Regional Cancer Center.
  • Rudresha, A. H., Abhishek Anand, K. C. Lakshmaiah, K. Govind Babu, D. Lokanatha, Amirtham Usha, Linu Abraham Jacob, Suresh Babu, K. N. Lokesh, L. K. Rajeev, and Deepak Koppaka. 2017. ‘Clinicopathological profile and treatment outcome of squamous cell carcinoma breast at a tertiary cancer center in South India’, memo – Magazine of European Medical Oncology, 10: 259-62.
  • Lakshmaiah, K. C., A. Anand, K. G. Babu, L. Dasappa, L. A. Jacob, M. C. S. Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, and D. Koppaka. 2017. ‘Role of Taxanes in Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center in South India’, World J Oncol, 8: 110-16.
  • Jacob, Linu, Abhishek Anand, Kuntegowdanahalli Lakshmaiah, Govind Babu, Dasappa Lokanatha, M Suresh Babu, Kadabur Lokesh, Antapura Rudresha, L Rajeev, and Deepak Koppaka. 2018. ‘Clinicopathological profile and treatment outcomes of bilateral breast cancer: A study from tertiary cancer center in South India’, Indian Journal of Medical and Paediatric Oncology, 39: 58-61.
  • Lokanatha, D., A. Anand, K. C. Lakshmaiah, K. Govind Babu, L. A. Jacob, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Koppaka, and R. V. Kumar. 2017. ‘Primary breast angiosarcoma – a single institution experience from a tertiary cancer center in South India’, Breast Dis.
  • Kadabur, L., D. Koppaka, G. B. Kanakasetty, A. Usha, L. C. Kuntegowdanahalli, L. Dasappa, L. A. Jacob, S. Babu, R. A. Haleshappa, A. Abhishek, and L. K. Rajeev. 2017. ‘Dual mutations and complex mutations in metastatic non-small cell lung cancer: A single-institution experience from South India’, Indian J Cancer, 54: 228-30.
  • Lakshmaiah, K. C., Asati, V. , Babu, K. G., Lokanath, D. , Jacob, L. A., Babu, M. C., Lokesh, K. N., Rajeev, L. K., Rudresh, A. H., Saldanha, S., Koppaka, D. , Patidar, R. and Premalata, C. S. (2018), Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B‐cell lymphoma. Eur J Haematol.
  • Govind Babu K, Anand Abhishek, Lakshmaiah Kuntegowdanahalli C, Lokanatha Dasappa, Jacob Linu Abraham, Babu MC Suresh, Lokesh Kadabur N, Rudresha Haleshappa A, Rajeev Lakkavalli K, Saldanha Smitha C, Giri GV, Chethan R, Koppaka Deepak, Panwar Dipti and Kumar Rekha V (2018) Correlation of BMI with breast cancer subtype and tumour size. ecancer 12 845.
  • Lokesh KN, Anand A, Lakshmaiah KC, Babu KG, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, G. V. Giri, D. Panwar, D. Koppaka, R. Patidar. Clinical profile and treatment outcomes of metastatic neuroendocrine carcinoma: A single institution experience. South Asian J Cancer 2018;7:207-9.
  • Haleshappa RA, Koppaka D, Kuntegowdanahalli LC, Kanakasetty GB, Dasappa L, Jacob LA, Mc Babu S, Lokesh KN. Pattern of malignancies in patients with HIV-AIDS: a single institution observational study. JCSO 2018;16(4):e188-e192.©2018 Frontline Medical Communications. doi: https://doi.org/10.12788/jcso.0416.
  • 15. Babu KG, Patidar R, Kuntegowdanahalli CL, Dasappa L, Jacob LA, Babu S, AH Rudresha, KN Lokesh, LK Rajeev, Koppaka D, Asati V. Metastatic synovial sarcoma: Experience from a tertiary care center from India. Indian J Med Paediatr Oncol 2018;XX:XX-XX.
  • Jacob LA, Asati V, Lakshmaiah KC, Govind B, Lokanatha D, Babu S, Lokesh KN, Rudresh AH, Rajeev LK, Mulchandani JN, Anand A, Koppaka D, Suma MN. Primary cutaneous B-cell lymphoma: A single-center 5-year experience. Indian J Cancer 2017;XX:XX-XX. DOI: 10.4103/ijc.IJC_418_17.
  • 16. Kanakasetty, G.B., Chethan, R., Lakshmaiah, K.C., Dasappa, L., Jacob, L.A., Babu, S., Lokesh, K.N., Haleshappa, R.A., Rajeev, L.K., Saldanha, S.C. and Deepak, K., 2019. Treatment patterns and comparative analysis of non-intensive regimens in elderly acute myeloid leukemia patients—a real-world experience from India. Annals of hematology, 98(4), pp.881-888.
  • 17. Balakrishnan, A., Koppaka, D., Anand, A., Deb, B., Grenci, G., Viasnoff, V., Thompson, E.W., Gowda, H., Bhat, R., Rangarajan, A. and Thiery, J.P., 2019. Circulating Tumor Cell cluster phenotype allows monitoring response to treatment and predicts survival. Scientific reports, 9(1), p.7933.
  • 18. Babu KG, D. Koppaka, Lokanatha D, Jacob LA, M. C. Suresh Babu, K. N. Lokesh, A. H. Rudresha, L. K. Rajeev, S. C. Saldanha, Anand A , Vikas A, Chethan R , Vedam L. Detection of clinically relevant Epidermal Growth Factor Receptor pathway mutations in circulating cell-free tumour DNA using Next Generation Sequencing in squamous cell carcinoma lung. South Asian J Cancer 2018
  • Ali MA, Babaiah M, Mariappan P, Sinha S, Muralidhar KR, Ponaganti S, Shah PA, Vuba SP, Gorla AKR, Koppaka D. A Rare Case of Recurrent Paget’s Disease of the Vulva and Gluteal Region Treated with Radiation Therapy. Appl Rad Oncol. 2020;9(1):44-47
  • II. Abstracts
  • 1. Jotwani AK, Jain R, Sharma V, Goud RS, Haranath R, Koppaka D, Mishra A, Komanduri SK, Chilukuri RP, Sangwan H. Development of" Online Cancer Patient Assistance Pathway"(OCPAP) technology platform to provide treatment guidance for cancer patients in developing countries.
  • 2. BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM INDIA: PB1752. HemaSphere. 2019 Jun 1;3:805.
  • 3. Rajegowda C, BABU G, KC L, JACOB AL, KN L, AH R, LK R, Koppaka D, Asati V, Patidar R. CXCR-4 EXPRESSION AND ITS PROGNOSTIC IMPACT IN DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS-SINGLE INSTITUTION EXPERIENCE FROM SOUTH INDIA: PB1704. HemaSphere. 2019 Jun 1;3:785.
  • 4. Koppaka D, Kuntegowdanahalli LC, Lokanath D, Govind Babu K, Jacob LA, Suresh Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Smitha SC, Anand A. 421O Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Annals of Oncology. 2018 Nov 1;29(suppl_9):mdy444-001.
  • 5. Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ as a patient-derived predictive platform for individualizing treatment in lung cancer. Annals of Oncology. 2018 Oct 1;29(suppl_8):mdy303-008.
  • 5. Babu G, Deepak K, Balakrishnan B, Biswas M, Prasath A, Radhakrishnan P, Chatterjee A, Thiyagarajan S, Chaudhuri P, Majumder PK. 1838P CANscript™ as a patient-derived predictive platform for individualizing treatment in lung cancer. Annals of Oncology. 2018 Oct 1;29(suppl_8):mdy303-008.
  • 7. Babu G, Koppaka D, Vl R. P2. 01-125 EGFR Mutations by NGS in Advanced Squamous Cell Lung Cancer. Journal of Thoracic Oncology. 2018 Oct 1;13(10):S713.
  • 8. Koppaka D, Lakshmaiah KC, Babu KG, Dasappa L, Jacob LA, Babu MC, Lokesh KN, Rudresha AH, Rajeev LK, Saldanha SC. 246P Clinical profile and outcomes of carcinoma anal canal: A single institution experience. Annals of Oncology. 2017 Nov 1;28(suppl_10):mdx660-053.

Research & Presentations

  • 1. Impact of integration of Positron Emission Tomography-Computer Tomography (PET-CT) in Radiotherapy planning of Non-Small Cell Carcinoma Lung (PGIMER) (Dissertation (M.D.)).
  • 2. Assessment and comparison of CISNE model versus MASCC model in clinically stable febrile neutropenia patients. Kidwai Cancer Institute (Dissertation (D.M.)).
  • 1. Ex vivoexpansion and characterization of circulating non-small cell lung cancer cells for individualized drug susceptibility testing. Kidwai Cancer Institution, Institute of Bio-Informatics (Project)
  • 2. Concordance between clinically relevant targetable mutations detected on tumor tissue and cell-free tumor DNA using next-generation sequencing in Non-Small Cell Lung Cancer: A prospective study. Kidwai Cancer Institution, Indian Institute of Science (Project).
  • 3. A study of recurrent /metastatic breast cancer in relation to their primary subtype, pattern of recurrence and the discordance rate of ER, PR and HER2. Kidwai Cancer Institute. (Project)
  • 4. A Prospective Study to Determine the Clinical Characteristics and Response to Treatment in Double Expressor DLBCL Among All DLBCL Patients in a Tertiary Care Hospital in South India. Kidwai Cancer Institute. (Project).
  • CXCR-4 expression and its correlation with Clinical- Biological characteristics in patients with Acute Myeloid Leukemia. Kidwai Cancer Institute. (Project).
  • 6. A Prospective study to evaluate Pathological, Radiological response, Toxicity profile, and Pharmacoeconomics of IAP and AP Regimens in localized high-grade osteosarcoma as Neoadjuvant chemotherapy (Project).
  • Role of pre-phase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma (Project)

Memberships

  • Association of Radiation Oncologists of India
  • European Society For Medical Oncology
  • American Society of Clinical Oncology
  • Indian Society of Medical and Pediatric Oncology
  • Indian Society of Oncology

Awards & Recognition

  • Silver Medal (first order) in MD Radiation Oncology at PGIMER, Chandigarh
  • Indian Society of Medical and Pediatric Oncology – Gold Medal (Best outgoing Medical Oncology Postgraduate), 2018
  • Indian Society of Medical and Pediatric Oncology – Torrent Young Scholar Award, 2018- First Prize
  • Indian Society of Medical and Pediatric Oncology- Torrent Young Scholar Award, 2018- Best Orator Award
  • European Society for Medical Oncology (ESMO) Asia 2018 Congress– Merit Award
  • Quiz (National Level Competitions) - First Prize - 36th ICON(Indian Cooperative Oncology Network), March 2017
  • Quiz (National Level Competitions) - Second Prize - 37th ICON(Indian Cooperative Oncology Network), September 2017
  • Quiz (National Level Competitions) - First Prize - Innovation in Oncology-Lung cancer edition, Indian Society of Oncology (ISO), April 2017
  • Quiz (National Level Competitions) - First Prize - 4th Sun's Platform for Education, Awareness & Knowledge (SPEAK), December 2017

Short-Biography

Working Hours
Hi-tech City

-10:00 am-5:00 pm

FEE ₹. 600
View All